MP
FNCH
MSD Partners’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,113
| Closed | -$26.5K | – | 70 |
|
|
2023
Q3 | $26.5K | Buy |
+5,113
| New | +$26.5K | ﹤0.01% | 57 |
|
|
2023
Q2 | – | Sell |
-5,113
| Closed | -$60.3K | – | 73 |
|
|
2023
Q1 | $60.3K | Hold |
5,113
| – | – | 0.01% | 52 |
|
|
2022
Q4 | $73.6K | Sell |
5,113
-7,843
| -61% | -$113K | 0.01% | 58 |
|
|
2022
Q3 | $649K | Hold |
12,956
| – | – | 0.05% | 50 |
|
|
2022
Q2 | $1.1M | Hold |
12,956
| – | – | 0.07% | 49 |
|
|
2022
Q1 | $1.96M | Sell |
12,956
-25,913
| -67% | -$3.91M | 0.11% | 44 |
|
|
2021
Q4 | $11.6M | Buy |
38,869
+25,913
| +200% | +$7.75M | 0.13% | 43 |
|
|
2021
Q3 | $5.05M | Buy |
12,956
+5,113
| +65% | +$1.99M | 0.15% | 32 |
|
|
2021
Q2 | $3.31M | Sell |
7,843
-5,113
| -39% | -$2.16M | 0.09% | 55 |
|
|
2021
Q1 | $6.28M | Buy |
+12,956
| New | +$6.28M | 0.24% | 34 |
|